Jun 22, 2026
16 MIN READ

Understanding When Side Effects of Wegovy Start and How to Manage Them

Semaglutide side effects typically emerge within days to weeks of starting treatment, with nausea and appetite suppression as the most common early experiences. Understanding the timeline helps patients distinguish expected adjustment symptoms from serious reactions.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 22, 2026
16 MIN READ

understanding when side effects of wegovy start and how to manage them — PlexusDx GLP-1 education

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist, triggers rapid changes in appetite signaling and gastric motility—which explains why side effects often appear within the first week of treatment. Most patients experience mild to moderate symptoms that peak around week 2–4, then gradually diminish as the body adapts. Knowing what to expect and how to manage it improves treatment adherence and success.

When Do Semaglutide Side Effects Start?

The majority of patients report their first side effects within 24–72 hours of the initial injection. Nausea stands out as the most frequently reported symptom during this early window, affecting up to 25–30% of users in clinical trials. Other patients experience appetite suppression, mild stomach discomfort, or changes in taste sensation within the same timeframe.

The onset timing depends on individual factors including body weight, metabolic sensitivity, injection site, and whether food was consumed near injection time. Slower injection technique and subcutaneous placement in areas with less blood flow may delay peak drug absorption and symptom onset by several hours. Patients starting with microdose protocols experience delayed side effect onset compared to standard starting doses.

Peak Side Effect Timeline and Duration

Side effects typically intensify during days 4–14 following injection, with peak severity occurring between days 7–10 in most patients. Nausea and loss of appetite generally reach their maximum impact during this window before beginning to decline. Constipation, fatigue, and dizziness may emerge later in this phase as secondary responses to reduced food intake and fluid shifts.

After the peak period, symptom intensity gradually diminishes over weeks 2–6 as the body's homeostatic mechanisms adapt to sustained GLP-1 signaling. By week 4–6, approximately 60–70% of patients report noticeable improvement in nausea severity. Full adaptation to side effects typically occurs by week 8–12, though some patients continue experiencing mild appetite suppression—which is actually the intended therapeutic effect.

Common Early Side Effects and Management Strategies

Nausea ranks as the most bothersome early side effect, but it responds well to dietary modifications including smaller meal portions, increased hydration, ginger supplementation, and avoiding high-fat or spicy foods. Eating slowly and chewing thoroughly gives the stomach more time to signal satiety to the brain before the patient overconsumes. Some patients find that taking the injection later in the evening, when they plan to eat less, naturally reduces nausea exposure.

Constipation emerges as a delayed side effect (often appearing after week 3–4) due to reduced caloric intake and slowed intestinal motility. Prevention strategies include daily fiber supplementation starting immediately upon treatment initiation, consuming at least 8–10 glasses of water daily, and gradually increasing physical activity. Stool softeners or mild osmotic laxatives provide additional relief without triggering the rebound diarrhea associated with stimulant laxatives.

Appetite suppression, while sometimes uncomfortable initially, becomes the mechanism driving weight loss success. Patients who frame this as a positive adaptation rather than a side effect experience improved psychological acceptance. Nutrient-dense foods like eggs, fish, Greek yogurt, and leafy vegetables maximize satiety and nutritional value within smaller meal volumes.

Genetic Factors That Influence Side Effect Severity

PlexusDx's Precision Peptide Genetic Test identifies variants in the GLP1R gene (rs6923761) and MC4R gene (rs17782313) that predict individual sensitivity to appetite suppression and nausea intensity. Patients carrying certain alleles may experience more pronounced early side effects but often achieve faster metabolic adaptation. Understanding personal genetic predisposition allows clinicians to adjust starting protocols—such as recommending the Microdose GLP-1 Protocol ($129/mo)—to minimize discomfort while maintaining efficacy.

The GIPR rs1800437 variant influences dual GLP-1 and GIP pathway activation, which affects both weight loss magnitude and gastrointestinal tolerance. Patients with specific GIPR genotypes may tolerate compounded tirzepatide (which activates both pathways) better than semaglutide despite higher initial nausea expectations. The Precision Peptide Genetic Test ($99 add-on after first month) maps 14 biological pathways and 150+ genetic insights to personalize both medication selection and dosing strategy.

When to Contact Your Healthcare Provider

Most side effects resolve independently within 6–8 weeks, but certain warning signs demand immediate medical attention. Severe vomiting lasting more than 24 hours, signs of dehydration (extreme thirst, dark urine, dizziness upon standing), severe abdominal pain, or difficulty swallowing require urgent evaluation to rule out serious complications. Persistent high fever or signs of allergic reaction (rash, swelling of face or throat) also warrant immediate contact with a healthcare provider.

Mild to moderate nausea, constipation, fatigue, and appetite loss fall within expected adjustment symptoms and typically improve with time and lifestyle modifications. Keeping a symptom diary helps patients and clinicians distinguish between temporary side effects and emerging patterns that may warrant dose adjustment or medication switching. PlexusDx providers work with patients to optimize tolerance while maintaining therapeutic benefit—your dose may need to go up, your price won't, allowing flexibility to match treatment to individual response.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly should I expect nausea to resolve after starting semaglutide?

Nausea typically peaks during the first 1–2 weeks and begins improving by week 3–4 as your body adapts to GLP-1 signaling. Most patients experience 50–70% reduction in nausea severity by week 6–8. If nausea persists beyond 8 weeks or worsens with each dose, consult your healthcare provider about dose timing or medication adjustments.

Why do side effects appear so quickly if semaglutide is injected weekly?

Semaglutide reaches peak blood levels within 24–72 hours of injection, immediately activating GLP-1 receptors throughout the brain and gut. This rapid receptor engagement triggers nausea, appetite suppression, and changes in gastric emptying before your body's compensatory mechanisms fully engage. Slower absorption from certain injection sites can slightly delay symptom onset but does not prevent them entirely.

Does PlexusDx offer a lower starting dose to minimize side effects?

Yes. PlexusDx's Microdose GLP-1 Protocol ($129/mo) provides a gentler entry point for patients prone to side effects or preferring slower adaptation. Compounded semaglutide injection starts at $149/mo with flexible dosing strategies. All PlexusDx medications are formulated by licensed 503A compounding pharmacies, allowing precise personalization without insurance requirements.

Can genetic testing predict whether I'll have severe side effects?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies variants in GLP1R, MC4R, and GIPR genes that influence nausea intensity, appetite suppression depth, and gastrointestinal tolerance. Patients with high-sensitivity genotypes benefit from microdose protocols or alternative peptides, while others tolerate standard doses immediately. Testing after your first month of treatment enables truly personalized medication optimization.

What if side effects don't improve after 8 weeks?

Persistent side effects beyond 8 weeks may indicate that your current formulation, dose, or compound isn't optimally suited to your biology. PlexusDx providers can explore switching to oral semaglutide, tirzepatide, or the GLP-Squared formula without price penalties—your dose may need to change, your monthly cost remains consistent. Genetic testing often identifies why one compound works better than another for your unique peptide pathways.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves